Latest News
-

Planting trees together: The 2016 Huntington's Disease Society of America Convention
⏱️ 6 min read
HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore
-

Huntingtin takes a trip: harmful proteins pass between brain cells
⏱️ 7 min read
Harmful misfolded huntingtin can travel between brain cells via messenger particles called exosomes
-

Important drug targets yielded by new genetic study of HD
⏱️ 8 min read
A genetic study confirms that minute differences in DNA repair genes can influence the age of HD symptom onset.
-

Thinking clearly about the earliest symptoms of HD and which brain regions control them
⏱️ 8 min read
HD reaches more brain structures than we thought: new research broadens our understanding of the earliest signs of HD
-

How NOT to write a news article about a clinical trial
⏱️ 5 min read
A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!
-

Huntington's Disease Therapeutics Conference 2016 – day 3
⏱️ 8 min read
Stem cells and modeling Huntington's disease in our final Therapeutics Conference report
-

Huntington's Disease Therapeutics Conference 2016 – day 2
⏱️ 7 min read
Strategies for getting rid of mutant huntingtin & clinical trial updates: day 2 of the HD therapeutics conference
-

Huntington's Disease Therapeutics Conference 2016 – day 1
⏱️ 12 min read
Proteins and DNA – Jeff and Ed report from day 1 of the 2016 #huntingtonsdisease therapeutics conference
-

Harnessing the power of viruses to treat Huntington's disease
⏱️ 7 min read
Researchers design a virus to more effectively deliver gene-silencing drugs throughout the brain.
-

Through a Broader Lens: Looking at Non-Motor Symptoms in HD
⏱️ 8 min read
Sleep deficits precede motor problems in HD
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
AMT-130 at Four Years: Hopeful Signs, Complex Controls
-
September 2026: This month in Huntington’s disease research
-
Studying Stutters: What 900,000 genomes teach us about growing DNA repeats
-
Highlighting Mental Health Disparities in Indigenous Communities Affected by Huntington’s Disease
-
Encouraging news from Skyhawk, as SKY-0515 Phase 1/2 data continues to hold promise
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
